Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mengniu is one of the world’s largest dairy companies, headquartered in Hohhot, Inner Mongolia. It produces liquid milk, yogurt, ice cream, cheese, and milk powder for consumers across China and internationally. Through its subsidiary Synaura Biotechnology, it has pioneered biosynthetic human milk oligosaccharide (HMO) production—becoming the first Chinese company to receive GRAS status from the US FDA for its HMO ingredient 2'-Fucosyllactose. These innovations are used primarily in infant formula products such as Enzhi series and Future Star liquid milk for children. The company reported annual revenue of RMB 88.67 billion (~$13.8 billion USD) in 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mengniu.